...just dropping this here as an historical marker in the interest of the shape of things to come.
If you search on line for cellular treatments it's usually all about cancer, which is fair enough because that stuff can kill you and researches really have gone back to the well (cell) to achieve breakthroughs. Potential effective MPC treatments due to fundamental systemic immunomodulatory and regenerative effects across human body systems and the already proven positive outcomes in heart and back and gut auger well for exciting times over the next 5 years.
Link: The secretion profile of mesenchymal stem cells and potential applications in treating human diseases
"...MSC-based clinical trials involve a variety of diseases in different organs and tissues. MSC-based clinical trials are mainly applied to the diseases associated with inflammation, wound healing, infection, as well as degeneration in diverse organs and tissues. The figure shows the types of diseases that have completed clinical trials (reproductive diseases and aging are not listed), and the most widely applied diseases involve the bone and nervous system. MSCs possess a strong capacity in balancing immune responses, especially in autoimmune disorders, such as GvHD and Crohn’s disease. As a lot of refractory diseases are often combined with poor repairing of damaged tissues and dysfunction of diseased organs, such as bones nonunion and multiple sclerosis, the clinicians also favor the multi-directional differentiation potential and pleiotropic effects of MSCs, to promote wound healing and functional recovery. In addition, researchers have been gradually investigating the therapeutic potential of MSC-based therapy in some congenital diseases. (Created with BioRender.com)..."
- Forums
- ASX - By Stock
- banter and General Discussion
...just dropping this here as an historical marker in the...
-
- There are more pages in this discussion • 408 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24054 | 0.935 |
8 | 131583 | 0.930 |
4 | 65851 | 0.925 |
7 | 113334 | 0.920 |
9 | 97006 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 1100 | 1 |
0.950 | 19026 | 2 |
0.955 | 27000 | 2 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online